Third Thursday--C&M's January Labor & Employment Update-Marijuana Legalization - Its Impact on Employer Drug and Alcohol Programs
Webinar | 01.22.15, 7:00 AM EST - 8:00 AM EST
Please join us for the next edition of Third Thursday – Crowell & Moring’s Labor and Employment Update, a webinar series dedicated to helping our clients stay on top of developing law and emerging compliance issues.
America is in the middle of a cultural revolution regarding the use of marijuana. Twenty-three states, plus the District of Columbia, have passed laws that authorize various types of use of marijuana for medical purposes. In November, voters in Alaska, Oregon, and the District of Columbia joined Colorado and Washington in approving laws allowing recreational use. And there are several states that have laws prohibiting organizations from discriminating against workers solely based on their status as medical marijuana patients. Yet possession and use of marijuana remain federal crimes. These developments present many employers with a dilemma as to how to manage drug and alcohol policies. Litigation pending in several jurisdictions raises questions as to whether employers may continue to ban the use of marijuana by employees and applicants, including cases arising under various state “lawful conduct” statutes.
Panelists on this month’s program will lead a discussion of the legal and practical issues facing employers seeking to maintain effective and enforceable drug & alcohol policies in response to these developments.
This webinar is scheduled for the fourth Thursday of January, Thursday, January 22 at 12:00 pm EST. We hope that you can join us and participate in a lively discussion of these issues.
Please click here to listen to a recording of the webinar. Please click here for a copy of the presentation.
For more information, please visit these areas: Labor and Employment
Participants
Insights
Webinar | 10.16.25
The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:
Webinar | 10.08.25
Webinar | 09.29.25
False Claims Act and Customs Enforcement—What You Need to Know
Webinar | 09.25.25